Betrixaban
Back to searchMolecule Structure
Scientific Name
Betrixaban
Description of the Drug
Betrixaban is a Factor Xa inhibitor used for prophylaxis of venous thromboembolism in hospitalized patients.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12364
http://www.drugbank.ca/drugs/DB12364
Brand Name(s)
Bevyxxa
Company Owner(s)
Portola Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Coagulation factor X | SINGLE PROTEIN | INHIBITOR | CHEMBL244 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL158591 | |
| Human Metabolome Database | HMDB0249167 | |
| DrugBank | DB12364 | |
| PubChem: Thomson Pharma | 15280787 | |
| PubChem | 10275777 | |
| LINCS | LSM-45445 | |
| Nikkaji | J2.867.473B | |
| BindingDB | 50249298 | |
| DrugCentral | 5241 | |
| Brenda | 85928 | 26670 |
| ChemicalBook | CB02500171 | |
| Guide to Pharmacology | 9602 | |
| rxnorm | BEVYXXA | BETRIXABAN |
| ChEBI | 140421 | |
| ZINC | ZINC000030691754 |
